Friday 30 October 2026 Export CVS’s income statement to Excel — free account

CVS Health Corporation

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

90.26 0.07 −0.08%

Follow CVS

Alert me

Market cap: $115.5B
P/E: 23.6×
Fwd P/E: 13.6×
Dividend yield: 2.95%
F-score: 7/9
Altman Z: 2.26
Beneish M: −2.64
Dividend safety: 43/100

Overview Business Profile Earnings & Analysis Segments Filings

CVS Health Corporation (CVS) revenue by segment, product and region

	Q4 FY2018	Q3 FY2018	Q2 FY2018	Q1 FY2018	Q4 FY2017	Q3 FY2017	Q2 FY2017	Q1 FY2017	Q4 FY2016	Q3 FY2016	Q2 FY2016	Q1 FY2016
Products	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Services	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Premiums	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other, not broken out	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Revenue	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.

CVS Health Corporation (CVS) revenue by segment, product and region

Stockrow Weekly